Walleye Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,100
Closed -$122K 5239
2020
Q3
$122K Sell
1,100
-1,200
-52% -$129K ﹤0.01% 3298
2020
Q2
$235K Buy
2,300
+2,200
+2,200% +$235K ﹤0.01% 2951
2020
Q1
$11K Sell
100
-1,100
-92% -$126K ﹤0.01% 3716
2019
Q4
$140K Sell
1,200
-6,900
-85% -$799K ﹤0.01% 3398
2019
Q3
$927K Sell
8,100
-7,100
-47% -$706K 0.01% 1656
2019
Q2
$1.45M Buy
+15,200
New +$1.43M 0.01% 1296

Walleye Trading's CBPO Position: Q4 2020 in Review

Walleye Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 230 shares — an estimated $26.7K sold.

Walleye Trading first reported a position in CBPO in Q2 2015 and held it in 6 quarters. The position peaked at $357K in Q3 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

  • Walleye Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
  • Walleye Trading sold 230 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $26.7K.
  • Walleye Trading first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 6 quarters.
  • Walleye Trading's China Biologic Products Holdings, Inc. position peaked at $357K in Q3 2019.
  • 89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.